Cabaletta Bio (CABA) Depreciation & Amortization (CF) (2019 - 2025)
Cabaletta Bio (CABA) posted quarterly Depreciation & Amortization (CF) of $348000.0 for Q4 2025, down 25.64% year-over-year from $468000.0 in Q4 2024, and up 0.87% quarter-over-quarter from $345000.0 in Q3 2025.
Cabaletta Bio (CABA) Depreciation & Amortization (CF) (2019 - 2025) Analysis & Trends
Cabaletta Bio's Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $348000.0 for Q4 2025.
- In Q4 2025, Depreciation & Amortization (CF) fell 25.64% year-over-year to $348000.0; the TTM figure through Dec 2025 stood at $1.6 million (down 3.8% YoY), while the FY2025 annual figure was $1.6 million, down 3.8% from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 stood at $348000.0, up from $345000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $485000.0 in Q1 2025, with the low at $116000.0 in Q1 2021.
- The 5-year median for Depreciation & Amortization (CF) is $356500.0 (2022), against an average of $334700.0.
- The sharpest annual moves came in 2021 and 2025: Depreciation & Amortization (CF) surged 145.56% in 2021, then dropped 25.64% in 2025.
- Cabaletta Bio's Depreciation & Amortization (CF) stood at $234000.0 in 2021, then soared by 52.99% to $358000.0 in 2022, then declined by 6.15% to $336000.0 in 2023, then surged by 39.29% to $468000.0 in 2024, then decreased by 25.64% to $348000.0 in 2025.
- Business Quant data shows CABA's Depreciation & Amortization (CF) at $348000.0 in Q4 2025, $345000.0 in Q3 2025, and $468000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 40.52 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Cabaletta Bio | 466.25 Mn | 466.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 348,000.00 |
| Dec 31, 2025 | 348,000.00 |
| Sep 30, 2025 | 345,000.00 |
| Sep 30, 2025 | 345,000.00 |
| Jun 30, 2025 | 468,000.00 |
| Jun 30, 2025 | 468,000.00 |
| Mar 31, 2025 | 485,000.00 |
| Mar 31, 2025 | 485,000.00 |
| Dec 31, 2024 | 468,000.00 |
| Dec 31, 2024 | 468,000.00 |
| Sep 30, 2024 | 424,000.00 |
| Sep 30, 2024 | 424,000.00 |
| Jun 30, 2024 | 426,000.00 |
| Jun 30, 2024 | 426,000.00 |
| Mar 31, 2024 | 393,000.00 |
| Mar 31, 2024 | 393,000.00 |
| Dec 31, 2023 | 336,000.00 |
| Dec 31, 2023 | 336,000.00 |
| Sep 30, 2023 | 355,000.00 |
| Sep 30, 2023 | 355,000.00 |